摘要:
Provided herein are compounds identified as inhibitors of ADAR1 activity, such as compounds having the formula: (I) or (II), or a pharmaceutically acceptable salt or tautomer thereof, that are useful in treating cancer and other disorders, include those related to abnormal ADAR1 expression.